Skip to main content
. 2020 Jul 14;10(7):e036347. doi: 10.1136/bmjopen-2019-036347

Table 2.

Summary questions presented in second online survey for interim prioritisation (50 in total)

1. How can we optimise information giving for those at risk of or affected by pregnancy hypertension?
2. How can pregnancy hypertension (including pre-eclampsia) be prevented in a subsequent pregnancy?
3. What is the cause of pregnancy hypertension (including pre-eclampsia)?
4. What can be done prior to pregnancy to reduce the risk of pregnancy hypertension?
5. What is the best way to manage pre-eclampsia?
6. How can we provide better support for women with pregnancy hypertension and their families?
7. What is the best way to diagnose pre-eclampsia promptly?
8. What is the effectiveness and safety of antihypertensive agents at reducing blood pressure in women with pregnancy hypertension?
9. What are the long-term consequences of pre-eclampsia for the woman and baby?
10. What is the effectiveness and safety of pharmacological treatments once pre-eclampsia is diagnosed?
11. How does the placenta contribute to pre-eclampsia?
12. What is the optimal antihypertensive medication to use postnatally?
13. What is the best screening test for pre-eclampsia?
14. What are the optimum blood pressure thresholds (for initiation) and targets for antenatal antihypertensive treatment?
15. Is there a hereditary link in pre-eclampsia and are the risks different for daughters and sons after an affected pregnancy?
16. How can we predict complications of pregnancy hypertension (progression to pre-eclampsia)?
17. What is the optimal timing of delivery in women with pregnancy hypertension?
18. What interventions are effective and safe at reducing fetal growth restriction in women with pregnancy hypertension?
19. What are the long-term effects of pre-eclampsia on mental health?
20. Following pregnancy hypertension, what is the best way to prevent future long-term problems?
21. What are the educational needs of healthcare professionals managing women with pregnancy hypertension?
22. What are the fetal, infant and child outcomes in women taking antihypertensive agents?
23. How can we better prevent stillbirth in pre-eclampsia?
24. What are the optimum blood pressure thresholds (for initiation) and targets for postnatal antihypertensive treatment?
25. What prepregnancy management of women with chronic hypertension optimises pregnancy outcomes?
26. What is the optimal monitoring strategy for women before, during and after pregnancy hypertension (including in subsequent pregnancies)?
27. What are the risk factors for developing pregnancy hypertension and pre-eclampsia?
28. How can pregnancy hypertension (including pre-eclampsia) be prevented during a pregnancy?
29. What is the risk of pregnancy hypertension in a subsequent pregnancy?
30. What is the best test to predict pregnancy hypertension?
31. What methods are effective at measuring blood pressure in women with pregnancy hypertension (including self-monitoring, ambulatory, automated, manual)?
32. What is the paternal contribution to pre-eclampsia?
33. What are the characteristics of postpartum pre-eclampsia?
34. What is the safety of treatments for pregnancy hypertension for the fetus and infant?
35. What are the long-term effects of pre-eclampsia on cardiovascular disease for the woman and baby?
36. What are the long-term effects of pregnancy hypertension on subsequent maternal blood pressure?
37. What are the consequences of pregnancy hypertension on pre-eclampsia, birth weight and prematurity in that pregnancy?
38. What is the relationship between blood pressure in pregnancy and development of pregnancy hypertension?
39. What are the mechanisms for increased cardiovascular risk for a woman and her child?
40. What are the effects of lifestyle interventions (eg, diet, exercise) in reducing high blood pressure in pregnancy?
41. What are the short-term and long-term health implications for infants of women with pregnancy hypertension and can these be modified?
42. What are the long-term neurodevelopmental implications of pregnancy hypertension for the child?
43. How does pregnancy hypertension affect the growth of the baby?
44. What is the best way to follow up women who experience pregnancy hypertension?
45. Do pregnancy characteristics predict infant and child morbidity?
46. What is the effectiveness and safety of aspirin for prevention of pre-eclampsia?
47. What are the links between maternal emotional well-being and pregnancy hypertension?
48. What non-pharmacological treatments are effective in treating high blood pressure following pregnancy hypertension?
49. How do sleep disorders affect pregnancy hypertension?
50. What are patient-reported outcomes of interest related to hypertension in pregnancy?

The first 25 listed above were highly ranked in the survey and therefore brought forward to the final prioritisation workshop.